A large, cluster-randomized trial in Kenya demonstrates that mass drug administration of ivermectin to children reduces malaria infection incidence by 26%. As malaria control faces challenges from insecticide resistance and mosquito behavior changes, ivermectin’s ability to kill mosquitoes feeding on treated individuals offers a complementary tool. This reinforces ivermectin’s role in integrated malaria control strategies alongside bed nets and other measures.